Skip to content
Storytelling Co – Lifestyle
Author:
Femasys Inc.
Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update
April 1, 2026
Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors
March 18, 2026
Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment
March 10, 2026
Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment
March 10, 2026
←
Previous Page
1
2